$LNSR
LENSAR Inc

2023 Q3 Form 10-Q Financial Statement

#000095017023040659 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $9.795M $12.01M
YoY Change 26.42% 49.44%
Cost Of Revenue $4.918M $5.251M
YoY Change 27.44% 66.91%
Gross Profit $4.877M $6.761M
YoY Change 25.4% 38.21%
Gross Profit Margin 49.79% 56.29%
Selling, General & Admin $5.117M $7.854M
YoY Change -16.38% 3.77%
% of Gross Profit 104.92% 116.17%
Research & Development $1.527M $1.499M
YoY Change -3.17% -60.9%
% of Gross Profit 31.31% 22.17%
Depreciation & Amortization $880.0K $855.0K
YoY Change 218.84% -0.12%
% of Gross Profit 18.04% 12.65%
Operating Expenses $6.644M $9.353M
YoY Change -13.67% -17.98%
Operating Profit -$2.040M -$2.867M
YoY Change -50.04% -57.83%
Interest Expense $270.0K $111.0K
YoY Change 193.48% 184.62%
% of Operating Profit
Other Income/Expense, Net $265.0K $111.0K
YoY Change 188.04% 184.62%
Pretax Income $2.570M -$8.753M
YoY Change -164.39% 29.5%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $2.568M -$8.753M
YoY Change -164.34% 29.5%
Net Earnings / Revenue 26.22% -72.87%
Basic Earnings Per Share $0.13 -$0.81
Diluted Earnings Per Share -$0.23 -$0.81
COMMON SHARES
Basic Shares Outstanding 11.25M 11.10M
Diluted Shares Outstanding 11.96M 10.82M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.92M $25.47M
YoY Change 29.17% 1.07%
Cash & Equivalents $24.92M $25.47M
Short-Term Investments
Other Short-Term Assets $1.240M $903.0K
YoY Change -4.76% -26.59%
Inventory $17.48M $18.15M
Prepaid Expenses
Receivables $3.848M $3.223M
Other Receivables $260.0K $595.0K
Total Short-Term Assets $48.65M $49.16M
YoY Change 51.21% 39.65%
LONG-TERM ASSETS
Property, Plant & Equipment $482.0K $605.0K
YoY Change -24.57% -11.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.341M $2.476M
YoY Change -18.18% -16.07%
Total Long-Term Assets $22.21M $22.03M
YoY Change -1.86% -6.22%
TOTAL ASSETS
Total Short-Term Assets $48.65M $49.16M
Total Long-Term Assets $22.21M $22.03M
Total Assets $70.85M $71.20M
YoY Change 29.29% 21.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.936M $4.619M
YoY Change 12.26% 10.21%
Accrued Expenses $5.457M $4.321M
YoY Change 10.29% -1.17%
Deferred Revenue $1.064M $1.067M
YoY Change 34.85% 13.87%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.01M $10.56M
YoY Change 12.49% -5.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $560.0K $568.0K
YoY Change 2445.45% 1435.14%
Total Long-Term Liabilities $560.0K $568.0K
YoY Change 2445.45% 1435.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.01M $10.56M
Total Long-Term Liabilities $560.0K $568.0K
Total Liabilities $20.72M $24.76M
YoY Change 69.61% 79.44%
SHAREHOLDERS EQUITY
Retained Earnings -$108.0M -$110.5M
YoY Change 13.63% 21.43%
Common Stock $144.3M $143.2M
YoY Change 4.9% 5.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.38M $32.69M
YoY Change
Total Liabilities & Shareholders Equity $70.85M $71.20M
YoY Change 29.29% 21.29%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $2.568M -$8.753M
YoY Change -164.34% 29.5%
Depreciation, Depletion And Amortization $880.0K $855.0K
YoY Change 218.84% -0.12%
Cash From Operating Activities -$340.0K -$2.144M
YoY Change -92.77% -23.15%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $181.0K
YoY Change -100.0% -1910.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$181.0K
YoY Change -100.0% 1710.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -200.0K 19.82M
YoY Change -83.33% -2106.17%
NET CHANGE
Cash From Operating Activities -340.0K -2.144M
Cash From Investing Activities 0.000 -181.0K
Cash From Financing Activities -200.0K 19.82M
Net Change In Cash -540.0K 17.50M
YoY Change -90.85% -561.88%
FREE CASH FLOW
Cash From Operating Activities -$340.0K -$2.144M
Capital Expenditures $0.00 $181.0K
Free Cash Flow -$340.0K -$2.325M
YoY Change -92.76% -16.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001320350
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39473
dei Entity Registrant Name
EntityRegistrantName
LENSAR, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0125724
dei Entity Address Address Line1
EntityAddressAddressLine1
2800 Discovery Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32826
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
536-7271
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
LNSR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11246205
CY2023Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1691000
CY2022Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1415000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3320000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2814000
CY2023Q2 us-gaap Revenues
Revenues
12012000
CY2022Q2 us-gaap Revenues
Revenues
8038000
us-gaap Revenues
Revenues
20264000
us-gaap Revenues
Revenues
17378000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
5251000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
3146000
us-gaap Cost Of Revenue
CostOfRevenue
9183000
us-gaap Cost Of Revenue
CostOfRevenue
7794000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7854000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7569000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14609000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13847000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1499000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3834000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3149000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8622000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
275000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
551000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
596000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2867000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6798000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7228000
us-gaap Operating Income Loss
OperatingIncomeLoss
-13481000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5997000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5997000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
111000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8753000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6759000
us-gaap Net Income Loss
NetIncomeLoss
-13025000
us-gaap Net Income Loss
NetIncomeLoss
-13433000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.34
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10820000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10820000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10073000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10073000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10768000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10020000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10020000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25466000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14674000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
56000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3223000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6040000
CY2023Q2 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
12000
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
4000
CY2023Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
595000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
200000
CY2023Q2 us-gaap Inventory Net
InventoryNet
18152000
CY2022Q4 us-gaap Inventory Net
InventoryNet
11740000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1728000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1062000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
49164000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
33716000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
605000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
563000
CY2023Q2 lnsr Equipment Under Lease Net
EquipmentUnderLeaseNet
6159000
CY2022Q4 lnsr Equipment Under Lease Net
EquipmentUnderLeaseNet
6316000
CY2023Q2 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
25000
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
9000
CY2023Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1221000
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
442000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11571000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12122000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2476000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2685000
CY2023Q2 us-gaap Assets
Assets
71196000
CY2022Q4 us-gaap Assets
Assets
55844000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4619000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5422000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4321000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4700000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1067000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
768000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
549000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
531000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10556000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11421000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2033000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2272000
CY2023Q2 lnsr Warrant Liabilities Noncurrent
WarrantLiabilitiesNoncurrent
11602000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
568000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
167000
CY2023Q2 us-gaap Liabilities
Liabilities
24759000
CY2022Q4 us-gaap Liabilities
Liabilities
13860000
CY2023Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
20000
CY2022Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0
CY2023Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
20000
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
20000
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2023Q2 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
20000000
CY2022Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0
CY2023Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
13747000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9980000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11199000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11199000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11093000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11093000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
112000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
111000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
143111000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
139381000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110533000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97508000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
32690000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
41984000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71196000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55844000
us-gaap Profit Loss
ProfitLoss
-13025000
us-gaap Profit Loss
ProfitLoss
-13433000
us-gaap Depreciation
Depreciation
1158000
us-gaap Depreciation
Depreciation
1110000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
551000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
596000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
267000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
260000
lnsr Provision For Doubtful Accounts And Notes Receivable
ProvisionForDoubtfulAccountsAndNotesReceivable
-2000
lnsr Provision For Doubtful Accounts And Notes Receivable
ProvisionForDoubtfulAccountsAndNotesReceivable
125000
us-gaap Share Based Compensation
ShareBasedCompensation
3550000
us-gaap Share Based Compensation
ShareBasedCompensation
3244000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5997000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2844000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1871000
us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
1199000
us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
-149000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
666000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-470000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7265000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
818000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-804000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1497000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-668000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-232000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-422000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
236000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8840000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5397000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
189000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-189000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56000
lnsr Proceeds From Temporary Equity And Net Of Offering Costs
ProceedsFromTemporaryEquityAndNetOfOfferingCosts
14035000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
5605000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
181000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
212000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1200000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19821000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-988000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10792000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6441000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14674000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31637000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25466000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25196000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10000
lnsr Transfer From Inventories To Equipment Under Lease Net
TransferFromInventoriesToEquipmentUnderLeaseNet
1281000
lnsr Transfer From Inventories To Equipment Under Lease Net
TransferFromInventoriesToEquipmentUnderLeaseNet
1416000
lnsr Transfer From Inventories To Property And Equipment Net
TransferFromInventoriesToPropertyAndEquipmentNet
-428000
lnsr Transfer From Inventories To Property And Equipment Net
TransferFromInventoriesToPropertyAndEquipmentNet
34000
lnsr Accrued Offering Costs Related To Non Cash Investing And Financing Activities
AccruedOfferingCostsRelatedToNonCashInvestingAndFinancingActivities
289000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
41984000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1726000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4272000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
39438000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1824000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
181000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8753000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
32690000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
54879000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1607000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6674000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
49812000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
212000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1637000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6759000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
44902000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110533000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounting Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes to the condensed financial statements. The accounting estimates that require management’s most significant, difficult and subjective judgments include, but are not limited to, revenue recognition and allowance for expected credit losses, the valuation of notes receivable and inventory, the assessment of recoverability of intangible assets and their estimated useful lives, the valuation and recognition of stock-based compensation, operating lease right-of-use assets and liabilities, the recognition and measurement of current and deferred income tax assets and liabilities, and the valuation of warrant liabilities. Management evaluates its estimates on an ongoing basis as there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The COVID-19 pandemic and global macroeconomic conditions originating during the pandemic continue to directly and indirectly impact the Company’s business, results of operations and financial condition, including revenue, expenses, reserves and allowances. The Company continues to monitor developments that are highly uncertain, including supply chain disruptions and price increases, as well as the economic impact on domestic and international suppliers, customers, and markets. The Company assessed certain accounting matters that require consideration of forecasted financial information, including, but not limited to, its current expected credit losses, the carrying value of the Company's intangible assets and other long-lived assets, and valuation allowances in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of June 30, 2023 and through the date of this report. As a result of these assessments, there were no impairments or material increases in expected credit losses or valuation allowances that impacted the Company's condensed financial statements as of and for the three and six months ended June 30, 2023 and 2022. However, the Company's future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the condensed financial statements in future reporting periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of the date of issuance of these unaudited condensed interim financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities.</span></p>
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
332000
lnsr Contract With Customer Asset Recognised
ContractWithCustomerAssetRecognised
889000
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
250000
lnsr Contract With Customer Asset Write Off Due To Contract Modification
ContractWithCustomerAssetWriteOffDueToContractModification
-146000
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
825000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
935000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1324000
CY2023Q2 lnsr Warrant Derivative Liabilities
WarrantDerivativeLiabilities
11602000
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
11602000
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2022Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10321000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6623000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16944000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14564000
CY2023Q2 us-gaap Lease Income
LeaseIncome
1691000
CY2022Q2 us-gaap Lease Income
LeaseIncome
1415000
us-gaap Lease Income
LeaseIncome
3320000
us-gaap Lease Income
LeaseIncome
2814000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3223000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6040000
CY2023Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
595000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
200000
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1067000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
768000
lnsr Accounts Receivables Payment Terms
AccountsReceivablesPaymentTerms
P30D
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
56000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-26000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-6000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
16000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000
CY2023Q2 us-gaap Financing Receivable Change In Present Value Interest Income
FinancingReceivableChangeInPresentValueInterestIncome
20000
CY2022Q2 us-gaap Financing Receivable Change In Present Value Interest Income
FinancingReceivableChangeInPresentValueInterestIncome
3000
us-gaap Financing Receivable Change In Present Value Interest Income
FinancingReceivableChangeInPresentValueInterestIncome
32000
us-gaap Financing Receivable Change In Present Value Interest Income
FinancingReceivableChangeInPresentValueInterestIncome
8000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
24000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
63000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
130000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
11000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
182000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
626000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1633000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
970000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
637000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
633000
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
974000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
15705000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3155000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4704000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3687000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2194000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1361000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
486000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
118000
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6303000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4002000
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2753000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
797000
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
9096000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6941000
CY2023Q2 us-gaap Inventory Net
InventoryNet
18152000
CY2022Q4 us-gaap Inventory Net
InventoryNet
11740000
lnsr Fair Value Of Warrant Liabilities Assumptions Dividends
FairValueOfWarrantLiabilitiesAssumptionsDividends
0
CY2023Q2 lnsr Fair Value Of Warrant Liabilities Assumptions Dividends
FairValueOfWarrantLiabilitiesAssumptionsDividends
0
lnsr Additional Royalty Payments Percentage
AdditionalRoyaltyPaymentsPercentage
0.03
lnsr Employee Retention Credit Cares Act Retention Amount
EmployeeRetentionCreditCaresActRetentionAmount
1600000
CY2023Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1691000
CY2022Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1415000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3320000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2814000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
18762000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7191000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11571000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
18762000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6640000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12122000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P15Y
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
275000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
551000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
596000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
546000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1125000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1234000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1224000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1215000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1008000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5219000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11571000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2369000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3348000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
562000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
437000
CY2023Q2 lnsr Accrued Customer Advances
AccruedCustomerAdvances
90000
CY2022Q4 lnsr Accrued Customer Advances
AccruedCustomerAdvances
171000
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
184000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
120000
CY2023Q2 lnsr Accrued Offering Costs
AccruedOfferingCosts
401000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
715000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
624000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4321000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4700000
CY2023Q2 lnsr Stock And Warrants Issued During Period Shares Common Stock And Warrants
StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants
4367000
lnsr Warrant Liability Percentage Of Floor Rate On Volatility Input
WarrantLiabilityPercentageOfFloorRateOnVolatilityInput
1
us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
20000000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
5605000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
14395000
CY2023Q2 lnsr Fair Value Of Warrant Liabilities Assumptions Risk Free Interest Rate
FairValueOfWarrantLiabilitiesAssumptionsRiskFreeInterestRate
0.041
lnsr Fair Value Of Warrant Liabilities Assumptions Risk Free Interest Rate
FairValueOfWarrantLiabilitiesAssumptionsRiskFreeInterestRate
0.041
CY2023Q2 lnsr Fair Value Of Warrant Liabilities Assumptions Risk Free Interest Rate
FairValueOfWarrantLiabilitiesAssumptionsRiskFreeInterestRate
0.037
CY2023Q2 lnsr Fair Value Of Warrant Liabilities Assumptions Expected Term
FairValueOfWarrantLiabilitiesAssumptionsExpectedTerm
P4Y10M24D
lnsr Fair Value Of Warrant Liabilities Assumptions Expected Term
FairValueOfWarrantLiabilitiesAssumptionsExpectedTerm
P4Y10M24D
CY2023Q2 lnsr Fair Value Of Warrant Liabilities Assumptions Expected Term
FairValueOfWarrantLiabilitiesAssumptionsExpectedTerm
P5Y
CY2023Q2 lnsr Fair Value Of Warrant Liabilities Assumptions Expected Volatility
FairValueOfWarrantLiabilitiesAssumptionsExpectedVolatility
0.55
lnsr Fair Value Of Warrant Liabilities Assumptions Expected Volatility
FairValueOfWarrantLiabilitiesAssumptionsExpectedVolatility
0.55
CY2023Q2 lnsr Fair Value Of Warrant Liabilities Assumptions Expected Volatility
FairValueOfWarrantLiabilitiesAssumptionsExpectedVolatility
0.55
CY2023Q2 lnsr Fair Value Of Warrant Liabilities Assumptions Dividends
FairValueOfWarrantLiabilitiesAssumptionsDividends
0
lnsr Employee Retention Credit Cares Act Contingent Professional Fees
EmployeeRetentionCreditCaresActContingentProfessionalFees
250000
CY2023Q2 lnsr Employee Retention Credit Cares Act Retention Amount Recognized
EmployeeRetentionCreditCaresActRetentionAmountRecognized
0
lnsr Offering Costs
OfferingCosts
901000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.015
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.03
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Company has a single class of common stock in which stockholders are entitled to one vote for each share of common stock
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q2 lnsr Maximum Value Of Common And Preferred Stock And Other Securities Issuable
MaximumValueOfCommonAndPreferredStockAndOtherSecuritiesIssuable
100000000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.94
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
604
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1794
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3409000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.035
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.039
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.025
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.035
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.042
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1824000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1637000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3550000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3244000
CY2023Q2 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Remainder Of Fiscal Year
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationRemainderOfFiscalYear
1910000
CY2023Q2 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Next Twelve Months
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationNextTwelveMonths
2124000
CY2023Q2 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Year Two
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationYearTwo
1005000
CY2023Q2 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Year Three
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationYearThree
213000
CY2023Q2 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Year Four
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationYearFour
5000
CY2023Q2 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortization
5257000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8753000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6759000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13025000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13433000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10820000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10820000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10073000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10073000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10768000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10768000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10020000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10020000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.34
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5997000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5997000

Files In Submission

Name View Source Status
0000950170-23-040659-index-headers.html Edgar Link pending
0000950170-23-040659-index.html Edgar Link pending
0000950170-23-040659.txt Edgar Link pending
0000950170-23-040659-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lnsr-20230630.htm Edgar Link pending
lnsr-20230630.xsd Edgar Link pending
lnsr-ex31_1.htm Edgar Link pending
lnsr-20230630_cal.xml Edgar Link unprocessable
lnsr-20230630_def.xml Edgar Link unprocessable
lnsr-20230630_lab.xml Edgar Link unprocessable
lnsr-20230630_pre.xml Edgar Link unprocessable
lnsr-20230630_htm.xml Edgar Link completed
lnsr-ex31_2.htm Edgar Link pending
lnsr-ex32_1.htm Edgar Link pending
lnsr-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable